We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Incorporating a Biologic Nanopore into a Synthetic One Offers New Ways to Analyze DNA

By LabMedica International staff writers
Posted on 22 Dec 2010
Researchers reported a new kind of nanopore device that could help in developing fast and inexpensive genetic analysis. More...
The innovative method that combines synthetic and biologic materials to result in a tiny hole on a chip is able to measure and analyze single DNA molecules.

The investigators involved on the project were from Delft University of Technology (The Netherlands) and Oxford University (UK). "The first mapping of the human genome where the content of the human DNA was read off was completed in 2003 and it cost an estimated 3 billion US dollars. Imagine if that cost could drop to a level of a few 100 euro, where everyone could have their own personal genome sequenced. That would allow doctors to diagnose diseases and treat them before any symptoms arise,” Prof. Cees Dekker of the Kavli Institute of Nanoscience at Delft explained.

One promising device is called a nanopore: a minute hole that can be used to ‘read' data from a single molecule of DNA as it threads through the hole. New research by Dr. Dekker's group in collaboration with Prof. Hagan Bayley of Oxford University, has now demonstrated a new, much more robust type of nanopore device. It combines biologic and artificial building blocks.

Dr. Dekker noted, "Nanopores are already used for DNA analysis by inserting naturally occurring, pore-forming proteins into a liquid-like membrane made of lipids. DNA molecules can be pulled individually through the pore by applying an electrical voltage across it, and analyzed. One feature that makes this biologic technology especially difficult, however, is the reliance on the fragile lipid support layer. This new hybrid approach is much more robust and suitable to integrate nanopores into devices.

The new research, performed mainly by lead author Dr. Adam Hall, is a simple technique that involves implanting the pore-forming proteins into a robust layer in a silicon chip. Essentially, an individual protein is attached to a larger piece of DNA, which is then pulled through a premade opening in a silicon nitride membrane.

When the DNA molecule threads through the hole, it pulls the pore-forming protein behind it, ultimately lodging it in the opening and creating a strong, chip-based system that is custom-made for arrays and device applications. The researchers have shown that the hybrid device is fully functional and can be used to detect DNA molecules.

The scientists published their findings in the November 28, 2010, issue of the journal Nature Nanotechnology.

Related Links:

Delft University of Technology
Oxford University




Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
POC Helicobacter Pylori Test Kit
Hepy Urease Test
New
Thyroid Test
Anti-Thyroid EIA Test
New
Automatic CLIA Analyzer
Shine i6000
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: Accurate immunotherapy selection for esophageal and GEJ carcinomas depends on consistent PD-L1 assessment (credit: Adobe Stock)

FDA Approval Expands Use of PD-L1 Companion Diagnostic in Esophageal and GEJ Carcinomas

Esophageal and gastroesophageal junction carcinomas (GEJ) have a poor prognosis, with approximately 16,250 deaths in the United States in 2025 and a five-year relative survival of 21.9%.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.